z-logo
Premium
Retracted: Effects of a levonorgestrel intrauterine system versus a copper intrauterine device on menstrual changes and uterine artery Doppler
Author(s) -
Rezk Mohamed,
Elshamy Elsayed,
Shaheen AbdElhamid,
Shawky Mohamed,
Marawan Hala
Publication year - 2019
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1002/ijgo.12778
Subject(s) - medicine , levonorgestrel , uterine artery , intrauterine device , incidence (geometry) , obstetrics , gynecology , vaginal bleeding , menstruation , population , family planning , pregnancy , research methodology , gestation , physics , environmental health , biology , optics , genetics
Objective To compare the effects of a levonorgestrel‐releasing intrauterine system ( LNG ‐ IUS ) and a copper intrauterine device (Cu‐ IUD ) on menstrual changes and uterine artery Doppler indices. Methods A randomized clinical trial was conducted at Menoufia University Hospital, Egypt, between December 2016 and August 2017. 306 multiparous women desiring intrauterine contraception were randomly assigned to LNG ‐ IUS (n=152) or Cu‐ IUD (n=154). Uterine artery pulsatility index ( PI ) and resistant index ( RI ) were measured before use, and 3 and 6 months after insertion, and associations with abnormal bleeding were evaluated. Results Irregular bleeding was initially reported by 31 (74%) of 42 women in the LNG ‐ IUS group, and heavy menstrual bleeding by 53 (67%) of 79 women in the Cu‐ IUD group. Incidence of abnormal bleeding decreased over the 6‐month study period. Uterine artery PI was significantly correlated with abnormal bleeding at a cutoff of 1.35 with area under the curve ( AUC ) 0.93, sensitivity 88%, and specificity 100%, whereas uterine artery RI was significantly correlated with abnormal bleeding at a cutoff of 0.62 with AUC 0.1, sensitivity 96%, and specificity 100%. Conclusion LNG ‐ IUS ‐related abnormal bleeding was associated with changes in uterine artery blood flow that were not evident among Cu‐ IUD users. Pan African Clinical Trials Registry: PACTR 201701001900640.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom